©The Author(s) 2025.
World J Diabetes. Dec 15, 2025; 16(12): 112799
Published online Dec 15, 2025. doi: 10.4239/wjd.v16.i12.112799
Published online Dec 15, 2025. doi: 10.4239/wjd.v16.i12.112799
Table 3 Univariate and multivariate analysis of risk factors and clinical characteristics for low fecal elastase concentration
| Variables | Univariate analysis | Multivariate analysis | ||||
| Normal FEC, n = 62 | Abnormal FEC, n = 44 | P value | OR | 95%CI | P value | |
| Age (year) | 45.1 ± 11.7 | 47.3 ± 11.8 | 0.364 | |||
| Male sex | 26 (41.9) | 27 (61.4) | 0.049 | 3.14 | 1.30-8.06 | 0.013 |
| Female sex | 36 (58.1) | 17 (38.6) | ||||
| Smoking | 13 (21) | 16 (36.4) | 0.080 | |||
| Alcohol | 7 (11.3) | 12 (27.3) | 0.035 | |||
| DM duration (year) | 18.4 ± 10 | 20.8 ± 10.8 | 0.244 | |||
| DM-related complications | 19 (30.6) | 26 (59.1) | 0.004 | |||
| Retinopathy | 17 (27.4) | 25 (56.8) | 0.002 | 2.63 | 1.09-6.44 | 0.032 |
| Kidney disease | 8 (12.9) | 10 (22.7) | 0.184 | |||
| Neuropathy | 7 (11.3) | 8 (18.2) | 0.316 | |||
| Cardiovascular disease | 0 | 1 (2.3) | 0.415 | |||
| Peripheral arteriopathy | 1 (1.6) | 2 (4.5) | 0.569 | |||
| HbA1c (%) | 7.6 ± 0.9 | 8.1 ± 1.1 | 0.017 | 1.83 | 1.15-3.06 | 0.015 |
| Gastrointestinal symptoms | 27 (43.5) | 13 (29.5) | 0.143 | |||
| BMI (kg/m2) | 24.7 ± 3.9 | 26 ± 4.9 | 0.183 | |||
| Serum nutritional markers | ||||||
| Hemoglobin (g/dL) | 13.9 ± 1.3 | 14.3 ± 1.2 | 0.124 | |||
| Mean corpuscular volume (fL) | 92.2 ± 6.5 | 93.1 ± 5.8 | 0.449 | |||
| Lymphocytes (× 106/L) | 1713 ± 566 | 1920 ± 578 | 0.068 | |||
| Prothrombin index | 98.1 ± 4.1 | 98.6 ± 4.0 | 0.491 | |||
| Total proteins (g/L) | 7.0 ± 0.4 | 6.9 ± 0.4 | 0.507 | |||
| Albumin (g/dL) | 4.4 ± 0.3 | 4.4 ± 0.3 | 0.441 | |||
| Prealbumin (mg/dL) | 20.9 ± 5.4 | 20.8 ± 3.6 | 0.880 | |||
| Retinol binding protein (mg/dL) | 3.2 ± 1.3 | 3.2 ± 1.0 | 0.864 | |||
| Transferrin (mg/dL) | 232.9 ± 42.2 | 232.8 ± 42.9 | 0.995 | |||
| Ferritin (µg/L) | 100.5 ± 96.8 | 79.2 ± 71.2 | 0.226 | |||
| Cholesterol (mg/dL) | 180 ± 34.5 | 182 ± 33 | 0.798 | |||
| Triglycerides (mg/dL) | 64.3 ± 26.9 | 62.9 ± 40.4 | 0.220 | |||
| Vitamin A (mg/L) | 0.4 ± 0.2 | 0.4 ± 0.1 | 0.913 | |||
| Vitamin D (ng/mL) | 26.6 ± 10.3 | 23.7 ± 9.6 | 0.161 | |||
| Vitamin E (mg/L) | 13.3 ± 3.0 | 13.6 ± 3.9 | 0.642 | |||
| Vitamin B12 (ng/L) | 504.5 ± 286 | 367.5 ± 183 | 0.006 | |||
| Folic acid (µg/L) | 11.4 ± 5.2 | 11.7 ± 4.1 | 0.790 | |||
| Calcium (mg/L) | 9.4 ± 0.4 | 9.6 ± 0.3 | 0.027 | |||
| Iron (mg/dL) | 79.6 ± 31.5 | 91.1 ± 37.5 | 0.093 | |||
| Magnesium (mg/dL) | 1.9 ± 0.2 | 1.9 ± 0.2 | 0.180 | |||
| Zinc (µg/dL) | 75.3 ± 14.5 | 76.3 ± 13.5 | 0.742 | |||
- Citation: Bolado F, Zabalza L, de-Carlos J, Tamayo-Rodríguez I, Prieto-Martínez C, Hervás-Palacios N. Longitudinal assessment of pancreatic exocrine dysfunction in type 1 diabetes. World J Diabetes 2025; 16(12): 112799
- URL: https://www.wjgnet.com/1948-9358/full/v16/i12/112799.htm
- DOI: https://dx.doi.org/10.4239/wjd.v16.i12.112799